News Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T Relapse Staff September 11, 2023 Iframe sync Post navigation Previous: APRINOIA Therapeutics Announces Strategic Investment From The Alzheimer’s Drug Discovery Foundation (ADDF)Next: Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer More Stories Healthcare Medicaid News Benchmark Senior Living Selects Sunbound to Help Modernize Resident Billing and Payments Staff November 19, 2026 Healthcare Medicaid News Benchmark Senior Living Selects Sunbound to Help Modernize Resident Billing and Payments Staff November 19, 2026 Healthcare News Omega Healthcare Earns Voice of the Customer Elevate Honor Recognition from Everest Group in the Healthcare and Life Sciences Services Category Staff November 19, 2026